Statements (24)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:Company
|
| gptkbp:acquisition |
gptkb:Neurotech,_Inc.
|
| gptkbp:CEO |
gptkb:Thomas_Sandgaard
|
| gptkbp:employees |
Over 100
|
| gptkbp:founded |
1996
|
| gptkbp:founder |
gptkb:Thomas_Sandgaard
|
| gptkbp:headquarters |
gptkb:Englewood,_Colorado
|
| https://www.w3.org/2000/01/rdf-schema#label |
Zynex, Inc.
|
| gptkbp:industry |
Medical Devices
|
| gptkbp:market |
Approximately $300 million (2021)
|
| gptkbp:mission |
To improve the quality of life for patients.
|
| gptkbp:products |
Electrotherapy devices
Pain management devices Rehabilitation devices |
| gptkbp:regulatoryCompliance |
gptkb:FDA
|
| gptkbp:revenue |
$20 million (2020)
|
| gptkbp:service_area |
gptkb:United_States
|
| gptkbp:services |
Home healthcare
|
| gptkbp:stockExchange |
Yes
ZYXI |
| gptkbp:technology |
Electrotherapy
Transcutaneous electrical nerve stimulation (TENS) Neuromuscular_electrical_stimulation_(NMES) |
| gptkbp:website |
www.zynex.com
|